Innoviva (INVA) Free Cash Flow (2010 - 2026)

Innoviva (INVA) reported Free Cash Flow of $34.8 million for Q1 2026, down 28.44% on a YoY basis from $48.6 million in Q1 2025, and down 75.38% quarter-over-quarter from $141.3 million in Q3 2025.

Innoviva (INVA) Free Cash Flow (2010 - 2026) Analysis & Trends

Innoviva has reported Free Cash Flow for 17 years, with the latest figure at $34.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Free Cash Flow fell 28.44% year-over-year to $34.8 million; the trailing twelve-month figure through Mar 2026 stood at $220.2 million (down 0.61% YoY), and the FY2025 full-year result was $195.8 million, up 3.92% from the prior year.
  • Free Cash Flow for Q1 2026 stood at $34.8 million, down from $141.3 million in the prior quarter.
  • The five-year high for Free Cash Flow was $192.8 million in Q3 2022, with the low at $25.7 million in Q1 2023.
  • Historically, Free Cash Flow has averaged $78.5 million across 5 years, with a median of $48.6 million in 2025.
  • Annual changes were most pronounced in 2023 — Free Cash Flow plunged 73.85% — and 2024, when it jumped 44.43%.
  • Innoviva's Free Cash Flow stood at $192.8 million in 2022, then plunged by 44.22% to $107.5 million in 2023, then increased by 20.11% to $129.2 million in 2024, then gained by 9.38% to $141.3 million in 2025, then plunged by 75.38% to $34.8 million in 2026.
  • The last three Free Cash Flow figures came in at $34.8 million (Q1 2026), $141.3 million (Q3 2025), and $44.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -1.67 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -2.49 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.29 Bn
9 Abivax 90.15 Bn 90.15 Bn - 63,220.27
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn 34.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.79 Mn
Mar 31, 2026 34.79 Mn
Sep 30, 2025 141.30 Mn
Sep 30, 2025 141.30 Mn
Jun 30, 2025 44.07 Mn
Jun 30, 2025 44.07 Mn
Mar 31, 2025 48.62 Mn
Mar 31, 2025 48.62 Mn
Sep 30, 2024 129.18 Mn
Sep 30, 2024 129.18 Mn
Jun 30, 2024 43.72 Mn
Jun 30, 2024 43.72 Mn
Mar 31, 2024 37.05 Mn
Mar 31, 2024 37.05 Mn
Sep 30, 2023 107.55 Mn
Sep 30, 2023 107.55 Mn
Jun 30, 2023 38.18 Mn
Jun 30, 2023 38.18 Mn
Mar 31, 2023 25.65 Mn
Mar 31, 2023 25.65 Mn